AACE 2019 Annual Conference

FP1 - T2D Remission as a Therapeutic Goal

Friday, April 26
9:00 AM - 9:45 AM
Location: Convention Center Hall B

Roy Taylor, MD

Professor of Medicine and Metabolism
Newcastle university

Roy Taylor qualified in medicine at the University of Edinburgh, and is Professor of Medicine and Metabolism at Newcastle University and Honorary Consultant at Newcastle Hospitals NHS Trust. He has been conducting research on type 2 diabetes since 1978, and has used a wide range of methods to understand the condition. He created the Newcastle Magnetic Resonance Centre in 2006 and has focussed on developing techniques to elucidate how food is handled by the body in health and disease. Recently he has demonstrated that type 2 diabetes can be reversed to normal by decreasing liver and pancreas fat content, throwing light on the aetiology of a condition previously regarded as complex and heterogenous.


Send Email for Roy Taylor

W. Timothy Garvey, MD

University of Alabama at Birmingham

W. Timothy Garvey is the Butterworth Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham, Birmingham, AL, USA. Dr Garvey obtained his medical degree from Saint Louis University, completed residency training in internal medicine at Barnes Hospital, Washington University, and was a clinical fellow in endocrinology and metabolism at the University of Colorado Health Sciences Center and University of California, San Diego School of Medicine. Dr Garvey has achieved international recognition for his research in the metabolic, molecular and genetic pathogenesis of insulin resistance, type 2 diabetes and obesity. The Garvey laboratory has made important observations regarding the pathogenesis of human insulin resistance and has furthered understanding of the role of the glucose transport system in human insulin resistance. A further interest concerns the understanding of obesity as a disease and advancing medical models to improve care of patients with obesity.
During his time as an American Association of Clinical Endocrinologists (AACE) board member and Chair of the AACE Obesity Scientific Committee, Dr Garvey has been a leading contributor and author of numerous AACE initiatives. These include a position statement and proposition affirming obesity as a disease, the new medical diagnostic term for obesity, an obesity treatment algorithm, evidence-based obesity management guidelines and a cardiometabolic disease staging system. Dr Garvey was Chair of the AACE Obesity Consensus Conference held in Washington, DC, USA in 2014.


Send Email for W. Timothy Garvey


FP1 - T2D Remission as a Therapeutic Goal


Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for T2D Remission as a Therapeutic Goal